You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美瑞健康國際(02327.HK)擬6274萬港元出售德馨醫藥開發全部股份及股東貸款
格隆匯 11-20 20:03

格隆匯 11 月 20日丨美瑞健康國際(02327.HK)公告,於2020年11月20日,賣方瑞麻國際控股有限公司(公司直接全資附屬公司)與買方宇城實業有限公司訂立協議,據此,賣方同意出售而買方同意收購相當於目標公司德馨醫藥開發有限公司全部已發行股待售股份以及股東貸款,總代價為6274萬港元。

目標公司主要從事買賣健康醫療產品、物業投資及租賃。於公告日期,目標公司擁有位於香港中環金鐘道89號力寶中心1座29樓6室物業("該物業")。 

公司主要從事投資控股。集團主要從事健康醫療相關業務、貿易業務、銷售代理業務、物業投資及租賃業務以及物業發展業務。

考慮到集團現時財務狀況及業務營運,董事認為出售事項乃公司以有利價格變現目標公司及該物業價值的良機,且出售事項的所得款項將改善集團的財務狀況及增加一般營運資金。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account